Top Page
Winshine Science Co., Ltd.
(0209)
Winshine Science Co., Ltd. (0209) vs. iShares MSCI Hong Kong ETF (EWH)
Winshine Science Co., Ltd. Business Overview & Revenue Model
Winshine Science Co., Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 473.15M | 515.91M | 523.26M | 849.10M | 724.63M | 364.31M |
| Gross Profit | -1.30M | 12.80M | 39.27M | 97.88M | 37.26M | 18.52M |
| EBITDA | -33.14M | -28.48M | 5.74M | 36.37M | -95.91M | -73.52M |
| Net Income | -84.76M | -73.03M | -28.65M | 8.08M | -136.01M | -95.78M |
Balance Sheet | ||||||
| Total Assets | 322.50M | 352.88M | 414.32M | 340.95M | 550.35M | 484.69M |
| Cash, Cash Equivalents and Short-Term Investments | 34.13M | 55.26M | 119.33M | 49.77M | 66.63M | 57.90M |
| Total Debt | 231.55M | 219.56M | 243.96M | 195.73M | 276.62M | 235.80M |
| Total Liabilities | 497.94M | 493.37M | 495.19M | 430.59M | 649.29M | 446.79M |
| Stockholders Equity | -173.78M | -139.04M | -80.06M | -89.65M | -98.94M | 37.90M |
Cash Flow | ||||||
| Free Cash Flow | 33.58M | -50.08M | -3.62M | 10.96M | -42.29M | -65.39M |
| Operating Cash Flow | 38.63M | -40.57M | 9.49M | 20.77M | -32.75M | -59.62M |
| Investing Cash Flow | -3.27M | -5.94M | -12.25M | 37.62M | 23.34M | 60.29M |
| Financing Cash Flow | -23.70M | -11.71M | 71.93M | -63.31M | 2.31M | -46.93M |
Winshine Science Co., Ltd. Technical Analysis
Winshine Science Co., Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | HK$64.00M | -9.20 | -32.53% | ― | -6.48% | -38.10% | |
50 Neutral | HK$45.31M | -18.57 | -1.26% | ― | 0.47% | -195.45% | |
46 Neutral | HK$224.08M | -11.76 | -50.25% | ― | -61.76% | 75.15% | |
45 Neutral | HK$219.88M | -0.41 | ― | ― | -7.53% | -93.37% | |
43 Neutral | HK$117.67M | -1.63 | -19.89% | ― | 84.26% | 44.41% | |
40 Neutral | HK$147.12M | -7.67 | -36.17% | ― | -13.96% | 64.58% |
Winshine Science Co., Ltd. Corporate Events
Winshine Science Company Limited, a firm incorporated in Bermuda, held a Special General Meeting (SGM) on December 5, 2025, where a proposed Rights Issue was approved by independent shareholders. The resolution passed with 73.21% of votes in favor, allowing the company to increase its issued shares by more than 50%. This decision is significant for the company’s capital structure and future growth opportunities, as it aligns with the Listing Rules requiring shareholder approval for such substantial share increases.
Winshine Science Co., Ltd. has announced a Special General Meeting to be held on December 5, 2025, to discuss and vote on a proposed Rights Issue. The Rights Issue involves the allotment of over 1.29 billion new shares at a subscription price of HK$0.14 per share, offered to existing shareholders on a seven-for-one basis. This initiative is aimed at raising capital, with Planetree Securities Limited underwriting the issue. The move is expected to impact the company’s financial structure and potentially influence its market position.
Winshine Science Company Limited has announced a change in its head office and principal place of business in Hong Kong, effective from November 1, 2025. This move includes updates to their telephone and facsimile numbers, reflecting a strategic relocation to the Great Eagle Centre in Wanchai. This change signifies a potential shift in the company’s operational focus and could impact its market presence and stakeholder engagement.
Winshine Science Co., Ltd. announced a change in its company secretary and authorized representative roles, effective October 17, 2025. Ms. Yu Nga Yan has resigned from her position, and Ms. Chan Yuk Yee, a seasoned professional with extensive experience in corporate governance, has been appointed as her successor. The company expressed gratitude to Ms. Yu for her contributions and welcomed Ms. Chan to her new role. This change is expected to strengthen the company’s governance practices and ensure compliance with Hong Kong’s regulatory requirements.
Winshine Science Co., Ltd. has announced a proposed rights issue, offering seven rights shares for every existing share at a subscription price of HK$0.14 per rights share, aiming to raise approximately HK$182 million. The rights issue is fully underwritten, with substantial shareholder Ms. Wang and her corporation, Peak Access, providing irrevocable undertakings to subscribe to their entitlements, potentially strengthening the company’s financial position and market presence.
Winshine Science Co., Ltd. announced significant changes in its executive leadership and board committees. Mr. Weng Zudian resigned as Executive Director and CEO, with Ms. Wang Jingyu taking over as CEO while retaining her role as Chairlady of the Board. Additionally, Ms. Wang Yumei resigned as an Independent Non-executive Director, and Mr. Wu Jiwei was appointed to this role and joined the Audit, Remuneration, and Nomination Committees. These changes aim to ensure a smooth transition and potentially strengthen the company’s governance and strategic direction.
Winshine Science Co., Ltd., listed on the stock exchange under the code 209, has updated its board of directors. The company has appointed Ms. Wang Jingyu as the Chairlady and Chief Executive Officer, alongside other executive, non-executive, and independent non-executive directors. This update reflects the company’s commitment to strengthening its governance structure, potentially impacting its strategic direction and stakeholder confidence.
Winshine Science Co., Ltd. has announced several measures to address liquidity and financial challenges, following a disclaimer of opinion on its going concern status. The company completed a placing agreement to raise funds, which are being used to repay loans, settle fees, and support working capital. Additionally, the company is negotiating with bondholders and financial advisers to manage outstanding debts and is implementing cost-control measures in its toy production segment to improve financial stability.
Winshine Science Company Limited announced the resignation of Mr. Wong Danny F. as an Executive Director, effective 30 September 2025. Mr. Wong is stepping down to focus on other business engagements, and there are no disagreements with the Board regarding his departure. The Board expressed gratitude for his contributions, and the announcement is not expected to impact the company’s operations or stakeholder relations.
Winshine Science Co., Ltd., a company incorporated in Bermuda, has updated its board of directors. The board consists of executive directors including Ms. Wang Jingyu as Chairlady, Mr. Weng Zudian as CEO, and Mr. Yiu Chun Kong, along with non-executive director Mr. Lin Shaopeng and independent non-executive directors Ms. Wang Yumei, Ms. Wu Yan Yee, and Ms. Wong Tin Ying Jade. The announcement outlines the roles and functions of the directors, highlighting the composition of the board committees, which include the Audit, Remuneration, and Nomination Committees. This update is significant for stakeholders as it reflects the company’s governance structure and may impact its strategic direction.
Winshine Science Co., Ltd. has announced further details regarding the use of proceeds from Placing A and Placing B, which have been fully utilized for the group’s general working capital. Additionally, the company has clarified details about its New Share Option Scheme, including the number of options available for grant and a correction to the maximum number of new shares to be issued under the scheme. These updates aim to provide transparency and ensure stakeholders are informed about the company’s financial strategies and shareholder plans.
Winshine Science Co., Ltd. has successfully completed the placing of new shares under a general mandate, issuing approximately 30.95 million shares at HK$0.35 each, raising a net total of approximately HK$10.32 million. The proceeds will be allocated towards loan repayment, settlement of audit and professional fees, and general corporate purposes, including staff salaries. This strategic move alters the company’s shareholding structure, with public shareholders now holding a larger portion of shares, potentially impacting the company’s market positioning and stakeholder interests.
Winshine Science Co., Ltd. has entered into a Placing Agreement with Imagi Brokerage Limited to place 30,951,496 new shares at a price of HK$0.350 per share. This placement, representing 20% of the existing total issued shares, is expected to raise gross proceeds of HK$10,833,023.60, which will be used for loan repayment and general corporate purposes. The move is aimed at strengthening the company’s financial position and operational capabilities.